Nicotinamide Riboside in Hospitalized Patients

Sponsor: Oslo University Hospital
Collaborator: ChromaDex, Inc.

Purpose

Patients experiencing acute illness will often have a prolonged recovery time. The cause of this is unknown, but certain factors, like age, duration, and graveness of the illness, is associated with prolonged recovery. In this study, they will investigate whether NR can shorten the recovery phase and improve outcome after acute illness.

Study Design

Randomized to placebo or NR in increasing doses, double-blind, placebo controlled

Dose

250mg, 500mg, 1000mg, 2000mg NR

Length of Intervention

3 months

Intrinsic Capacity

Vitality

Status

Recruiting

Condition or Disease 

Inflammation
Acute Illness

Timeline estimations sourced on clinicaltrials.gov. All timing subject to change.

Clinical Studies, Vitality, RecruitingANAD Staff